Clinical Trial

A Virtual Reality Couples' Intervention for Sexual Victimization Prevention: a Gender-swapping Transformative Approach

Study acronym: REVISE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to evaluate the effectiveness of REVISE (REalidad Virtual Inmersiva y SExualidad), an immersive virtual reality (IVR) intervention designed to promote empathy and reduce sexual harassment behaviors in heterosexual cisgender men. The main questions that this study aims to answer are as follows. Does experiencing gender swapping in IVR increase empathy towards survivors of sexual harassment? Does the intervention modify attitudes toward gender roles and sexual harassment? Researchers will compare the three experimental groups to evaluate the effects of IVR: 1. Identity Exchange Group with Exposure to Sexual Harassment: Participants embodied their partner's identity in a VR harassment scenario. 2. Identity Exchange Group without Harassment Exposure: Participants embodied their partner's identity in a neutral VR scenario. 3. Third-person Observer Group: Participants observe a harassment scenario in VR from their own perspective. Participants will: 1. Attend one virtual reality session in a laboratory setting. 2. Undergo pre- and post-intervention assessments and a three-month follow-up. 3. Complete self-report questionnaires and physiological measures (eye tracking and pupillometry). 4. Participate in semi-structured interviews about their experiences. This study aims to explore how immersive VR embodiment can be used as a tool for gender violence prevention by fostering perspective-taking and behavioral change.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-02-17; most recent amendment 2026-03-18.
Trial Details
NCT Number NCT06839937
Lead Sponsor Universitat Oberta de Catalunya
Collaborators: Ministerio de Ciencia e Innovación, Spain, European Social Fund
Conditions Sexual Harassment, Gender Based Violence, Empathy, Virtual Reality Exposure Therapy
Enrollment 180 participants
Start Date 2027-03-30
Primary Completion 2027-03-30 (estimated)
Study Completion 2027-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-23